Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,792 companies covered Latest filing Oct 6 History loaded for 0 of 4,792

  • $731M bought by 141 insiders at 96 companies
  • $1.4B sold by 97 insiders outside a trading plan
  • $1.1B sold by 354 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past week · by insider, all their filings added up

  1. LENLennar Corporation
    Berkshire Hathaway Inc.10% owner · +1 joint filer
    3,079,047 shares at $80.06 Sep 28–Oct 2 · 2 filings 3 superinvestors bought in Q2
    $247M
  2. KODKodiak Sciences Inc
    Baker Bros. Advisors LPDirector · +5 joint filers
    1,941,755 shares at $80.85 Sep 28–29 · 3 filings +11% to stake 1 superinvestor sold in Q2
    $157M
  3. UUUUniversal Safety Products, Inc.
    Milton C Ault IIIDirector
    18,000 shares at $5,134.00 Sep 30 +1.6% to stake
    $92.4M
  4. CRBGCorebridge Financial Inc.
    Life Insurance Co Nippon10% owner
    2,009,018 shares at $33.91 Sep 25–Oct 2 · 6 filings +1.6% to stake 2 superinvestors bought in Q2
    $68.1M
  5. GPIGroup 1 Automotive, Inc.
    Conifer Management, L.L.C.10% owner
    273,712 shares at $242.15 Sep 28–30 +17% to stake 2 superinvestors bought in Q2
    $66.3M
  6. GMEGameStop Corporation
    Ryan CohenCEO
    1,150,000 shares at $24.04 Sep 29–Oct 2 · 2 filings +2.8% to stake
    $27.6M
  7. COURCoursera, Inc.
    Pale Fire Capital SE10% owner · +4 joint filers
    2,332,742 shares at $4.87 Sep 25–29 +8.8% to stake
    $11.4M
  8. AVRAnteris Technologies Global Corp.
    L1 Capital Pty Ltd10% owner
    1,282,035 shares at $7.59 Sep 30–Oct 5 · 2 filings +11% to stake
    $9.7M
  9. BORRBorr Drilling Limited
    Tor Olav TroimDirector
    1,500,000 shares at $4.13 Oct 5 +4.9% to stake
    $6.2M
  10. PAMPampa Energia S.A.
    Damian Miguel MindlinVicepresident
    1,432,197 shares at $3.89 Sep 28
    $5.6M

Biggest sales

Past week · by insider, all their filings added up · planned sales marked

  1. MDLNMedline Inc.
    GIC Private Ltd10% owner · +2 joint filers
    20.7M shares at $34.90 Oct 2–6
    $722M
  2. THTarget Hospitality Corp.
    TDR Capital II Investments LP10% owner · +9 joint filers
    11M shares at $18.40 Oct 1 40% of stake
    $202M
  3. ESTCElastic N.V.
    Steven SchuurmanDirector
    1,500,000 shares at $90.13 Oct 5 25% of stake
    $135M
  4. NBISNebius Group N.V.
    Ophir NaveCOO
    500,000 shares at $235.53 Oct 5 52% of stake Planned sale (10b5-1)
    $118M
  5. BEKEKE Holdings Inc
    Yongdong PengCEO
    16M shares at $5.27 Sep 25 20% of stake
    $84.6M
  6. CBRSCerebras Systems Inc.
    Dhiraj MallickCOO
    396,000 shares at $204.04 Sep 29 100% of stake Planned sale (10b5-1)
    $80.8M
  7. CRWDCrowdStrike Holdings, Inc.
    Michael SentonasPresident
    241,944 shares at $265.45 Sep 30 16% of stake Planned sale (10b5-1)
    $64.2M
  8. AAPLApple Inc Com
    Timothy D CookChair
    191,753 shares at $332.96 Oct 2 5.5% of stake Planned sale (10b5-1)
    $63.8M
  9. MPWRMonolithic Power Systems, Inc.
    Michael HsingCEO
    30,000 shares at $1,344.97 Sep 28 3.5% of stake Planned sale (10b5-1)
    $40.3M
  10. ACTEnact Holdings, Inc.
    Genworth Holdings, Inc.10% owner
    762,894 shares at $48.65 Sep 30 0.7% of stake
    $37.1M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days · most buyers first

  1. SPGSimon Property Group, Inc. 11 insiders · $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  2. SBLKStar Bulk Carriers Corp. 7 insiders · $4.8M

    Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more

    Latest buy Sep 15 3 executives 1 superinvestor bought in Q2
  3. FULH. B. Fuller Company 7 insiders · $621K

    Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more

    Latest buy Sep 30 1 superinvestor bought in Q2
  4. RWTRedwood Trust, Inc. 6 insiders · $969K

    Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more

    Latest buy Sep 21 5 executives
  5. MPBMid Penn Bancorp 6 insiders · $32K

    Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more

    Latest buy Sep 30 1 executive
  6. PMTSCPI Card Group Inc. 5 insiders · $12M

    Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more

    Latest buy Sep 14 1 executive
  7. XBPXBP Global Holdings, Inc. 5 insiders · $2.4M

    Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more

    Latest buy Sep 15 2 executives
  8. ATCHAtlasClear Holdings, Inc. 5 insiders · $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  9. RGCORGC Resources Inc. 5 insiders · $107K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  10. RVSBRiverview Bancorp Inc 5 insiders · $51K

    Kourosh Nasser Zamanizadeh Director, Bessie Ross Wills Director, Nicole Sherman CEO, Stacey Graham Director, +1 more

    Latest buy Sep 17 2 executives

All insider trades

Newest filings first · one row per filing · every open-market buy and sale

  1. Horizon Kinetics Asset Management LLC 10% owner
    TPLTexas Pacific Land Corporati
    Buy
    $1,364 4 shares at $340.96 +<0.1% to stake
    Traded Sep 29 Filed Oct 1
  2. Marta R Stewart Director
    SPGSimon Property Group, Inc.
    Buy
    $40K 199 shares at $202.78 +1.1% to stake
    Traded Sep 30 Filed Oct 1
  3. Daniel C. Smith Director
    SPGSimon Property Group, Inc.
    Buy
    $71K 350 shares at $202.78 +1% to stake
    Traded Sep 30 Filed Oct 1
  4. Stefan M Selig Director
    SPGSimon Property Group, Inc.
    Buy
    $42K 208 shares at $202.78 +0.6% to stake
    Traded Sep 30 Filed Oct 1
  5. Gary M Rodkin Director
    SPGSimon Property Group, Inc.
    Buy
    $47K 232 shares at $202.78 +1.1% to stake
    Traded Sep 30 Filed Oct 1
  6. Randall J Lewis Director
    SPGSimon Property Group, Inc.
    Buy
    $13K 65 shares at $202.78 +0.9% to stake
    Traded Sep 30 Filed Oct 1
  7. Reuben S Leibowitz Director
    SPGSimon Property Group, Inc.
    Buy
    $97K 480 shares at $202.78 +0.9% to stake
    Traded Sep 30 Filed Oct 1
  8. Nina P Jones Director
    SPGSimon Property Group, Inc.
    Buy
    $9,328 46 shares at $202.78 +1.1% to stake
    Traded Sep 30 Filed Oct 1
  9. Larry C Glasscock Director
    SPGSimon Property Group, Inc.
    Buy
    $74K 367 shares at $202.78 +0.8% to stake
    Traded Sep 30 Filed Oct 1
  10. Martin J Cicco Director
    SPGSimon Property Group, Inc.
    Buy
    $3,042 15 shares at $202.78 +1.1% to stake
    Traded Sep 30 Filed Oct 1
  11. Glyn Aeppel Director
    SPGSimon Property Group, Inc.
    Buy
    $45K 222 shares at $202.78 +1.1% to stake
    Traded Sep 30 Filed Oct 1
  12. Alejandro Gustavo Elsztain CEO
    CRESYCresud S.A.C.I.F. y A.
    Buy
    $199K 17,334 shares at $11.50 +1.4% to stake
    Traded Sep 30–Oct 1 Filed Oct 1
  13. Michael J Happe Director
    FULH. B. Fuller Company
    Buy
    $99K 2,000 shares at $49.63 +149% to stake
    Traded Sep 29 Filed Oct 1
  14. Celine Christine Martin Director
    FULH. B. Fuller Company
    Buy
    $23K 465 shares at $49.50 New stake
    Traded Sep 30 Filed Oct 1
  15. Francisco Gonzalez CFO
    SKYHSky Harbour Group Corporation
    Buy
    $15K 1,500 shares at $9.69 +0.2% to stake
    Traded Sep 30 Filed Oct 1
  16. Thomas Patrick Kelly CFO
    XENEXenon Pharmaceuticals Inc.
    Buy
    $560K 15,000 shares at $37.32 New stake
    Traded Sep 30 Filed Oct 1
  17. Ian Mortimer CEO
    XENEXenon Pharmaceuticals Inc.
    Buy
    $1.1M 30,000 shares at $37.38 +151% to stake
    Traded Sep 30 Filed Oct 1
  18. Richard Barry CEO
    FLNAFilana Therapeutics, Inc.
    Buy
    $278K 306,813 shares at $0.9100 +30% to stake
    Traded Sep 29–30 Filed Oct 1
  19. Kun Dai CEO
    UXINUxin Limited
    Buy
    $9,945 7,443 shares at $1.34 +88% to stake
    Traded Sep 30 Filed Oct 1
  20. Milton C Ault III Chair · +1 joint filer
    GPUSHyperscale Data, Inc.
    Buy
    $5.1M 10.3M shares at $0.4900
    Traded Sep 29–30 Filed Oct 1
  21. Conifer Management, L.L.C. 10% owner
    GPIGroup 1 Automotive, Inc.
    Buy
    $66.3M 273,712 shares at $242.15 +17% to stake
    Traded Sep 28–30 Filed Sep 30
  22. John W. Higuchi Director
    LPCNLipocine Inc.
    Buy
    $27K 12,561 shares at $2.16 +6.2% to stake
    Traded Sep 28 Filed Sep 30
  23. Berkshire Hathaway Inc. 10% owner · +1 joint filer
    LENLennar Corporation
    Buy
    $53.9M 660,410 shares at $81.59
    Traded Sep 28–30 Filed Sep 30
  24. Peter Altman CEO
    BCDABioCardia, Inc.
    Buy
    $1,030 1,000 shares at $1.03 +0.3% to stake
    Traded Sep 29 Filed Sep 30
  25. Jacob Bistricer COO
    CLPRClipper Realty Inc.
    Buy
    $246K 73,500 shares at $3.35 New stake
    Traded Sep 28 Filed Sep 30
  26. Paul Seid Director
    INLXIntellinetics, Inc.
    Buy
    $948 184 shares at $5.15 +0.1% to stake
    Traded Sep 28–30 Filed Sep 30
  27. Joshua Horowitz Director
    KWYKingsway Corporation
    Buy
    $33K 3,575 shares at $9.26 +0.9% to stake
    Traded Sep 28–30 Filed Sep 30
  28. William P Scully 10% owner
    PRTAProthena Corporation plc
    Buy
    $1.4M 162,000 shares at $8.68 +312% to stake
    Traded Sep 29 Filed Sep 30
  29. Life Insurance Co Nippon 10% owner
    CRBGCorebridge Financial Inc.
    Buy
    $27.5M 805,782 shares at $34.15 +0.6% to stake
    Traded Sep 28 Filed Sep 30
  30. Robert Thomas Devincenzi Director
    UTIUniversal Technical Institute Inc
    Buy
    $20K 1,000 shares at $19.68 +0.7% to stake
    Traded Sep 28 Filed Sep 30
  31. John Taylor Maloney Fitzgerald CEO
    KWYKingsway Corporation
    Buy
    $2,502 269 shares at $9.30 +<0.1% to stake
    Traded Sep 30 Filed Sep 30
  32. Kent A Hansen CFO
    KWYKingsway Corporation
    Buy
    $1,572 169 shares at $9.30 +0.1% to stake
    Traded Sep 30 Filed Sep 30
  33. Sergey Losyev Co-Chief Investment Officer
    ARRARMOUR Residential REIT, Inc.
    Buy
    $10K 725 shares at $13.91 +8.1% to stake
    Traded Sep 29 Filed Sep 30
  34. Leonard M Tannenbaum Director
    AFCGAdvanced Flower Capital Inc.
    Buy
    $344K 95,397 shares at $3.61 +1.4% to stake
    Traded Sep 28–30 Filed Sep 30
  35. Baker Bros. Advisors LP Director · +5 joint filers
    KODKodiak Sciences Inc
    Buy
    $63.4M 715,592 shares at $88.59 +3.7% to stake
    Traded Sep 28–29 Filed Sep 30
  36. William B. Horne CEO
    GPUSHyperscale Data, Inc.
    Buy
    $16K 100,000 shares at $0.1600 +25% to stake
    Traded Sep 30 Filed Sep 30
  37. Baker Bros. Advisors LP Director · +5 joint filers
    KODKodiak Sciences Inc
    Buy
    $35M 418,323 shares at $83.58 +2.2% to stake
    Traded Sep 28 Filed Sep 30
  38. Baker Bros. Advisors LP Director · +5 joint filers
    KODKodiak Sciences Inc
    Buy
    $58.6M 807,840 shares at $72.57 +4.4% to stake
    Traded Sep 28 Filed Sep 30
  39. Stanley Frankel Director
    DTILPrecision BioSciences, Inc.
    Buy
    $6,000 1,000 shares at $6.00 +2.5% to stake
    Traded Sep 28 Filed Sep 30
  40. James L Robo Director
    KBDCKayne Anderson BDC, Inc.
    Buy
    $1.9M 146,755 shares at $13.03 +24% to stake
    Traded Sep 28 Filed Sep 30
  41. Richard Barry CEO
    FLNAFilana Therapeutics, Inc.
    Buy
    $78K 93,091 shares at $0.8400 +9.9% to stake
    Traded Sep 28 Filed Sep 30
  42. Ronald Todd Plott Director
    PHIOPhio Pharmaceuticals Corp.
    Buy
    $10K 10,000 shares at $1.04 +31% to stake
    Traded Sep 28–29 Filed Sep 30
  43. Thomas W Handley Director
    FULH. B. Fuller Company
    Buy
    $99K 2,000 shares at $49.41 New stake
    Traded Sep 28 Filed Sep 30
  44. Daniel L Florness Director
    FULH. B. Fuller Company
    Buy
    $100K 2,030 shares at $49.34 +150% to stake
    Traded Sep 28 Filed Sep 30
  45. Trangsrud Teresa J Rasmussen Director
    FULH. B. Fuller Company
    Buy
    $100K 2,042 shares at $48.96 +102% to stake
    Traded Sep 28 Filed Sep 30
  46. Charles T Lauber Director
    FULH. B. Fuller Company
    Buy
    $100K 2,005 shares at $49.87 +148% to stake
    Traded Sep 29 Filed Sep 30
  47. Srilata Zaheer Director
    FULH. B. Fuller Company
    Buy
    $100K 2,040 shares at $49.08 +152% to stake
    Traded Sep 28–29 Filed Sep 30
  48. Yair Nechmad Chair
    NYAXNayax Ltd.
    Buy
    $2.1M 46,935 shares at $44.90 +0.6% to stake
    Traded Sep 28–29 Filed Sep 30
  49. Michael Catelani CFO
    ANIXAnixa Biosciences, Inc.
    Buy
    $16K 5,500 shares at $2.84 +12% to stake
    Traded Sep 30 Filed Sep 30
  50. Robert George Culp IV CEO
    CULPCulp, Inc.
    Buy
    $12K 2,960 shares at $3.89 +2.2% to stake
    Traded Sep 28 Filed Sep 30

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.